Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on New Hampshire Health Report.
Press releases published on May 21, 2025
Verona Pharma Announces June 2025 Investor Conference Participation
GlobeNewswire
·
May 21, 2025
LONDON and RALEIGH, N.C., May 21, 2025 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”) announces that senior management will participate in fireside chats at the following conferences in June 2025: Jefferies Global …
Verano to Celebrate Grand Opening of Zen Leaf Enfield, Company’s Seventh Connecticut Dispensary, Throughout Memorial Day Weekend
GlobeNewswire
·
May 21, 2025
Zen Leaf Enfield, located at 98 Elm St., adjacent to Enfield Square Mall, joins the local business community ahead of the Mall’s $250 million transformative redevelopment to “Enfield Marketplace” Verano provided funds to the Thompsonville Fire Department …
Curium and NRG PALLAS extend collaboration in the supply of essential medical isotope to hospitals
GlobeNewswire
·
May 21, 2025
PETTEN, The Netherlands, May 21, 2025 (GLOBE NEWSWIRE) -- NRG PALLAS and Curium have extended their collaboration to produce molybdenum-99 through a new multi-year agreement. Molybdenum-99, which transforms into technetium-99, is a critical isotope used in …
EuroPCR 2025: Najnowsze dane potwierdzają trwały i istotnie niższy odsetek niepożądanych zdarzeń klinicznych przy zastosowaniu bioadaptatora DynamX® firmy Elixir Medical w porównaniu do stentu uwalniającego lek (DES) w okresie trzech lat
GlobeNewswire
·
May 21, 2025
Paris, May 21, 2025 (GLOBE NEWSWIRE) -- — Trwały efekt terapeutyczny z istotnie niższym współczynnikiem niepowodzeń leczenia zmiany docelowej (TLF) – 2,7% wobec 7,2% (p=0,030) dla DynamX® w porównaniu do DES — — Istotnie niższy współczynnik zgonów sercowo- …
Juvenescence closes $76m first tranche of Series B-1 financing led by Abu Dhabi’s M42 alongside strategic partnership
GlobeNewswire
·
May 21, 2025
Juvenescence closes $76m first tranche of Series B-1 financing led by Abu Dhabi’s M42 alongside strategic partnership Close of $76m Series B-1 tranche follows recent announcement of groundbreaking strategic partnership with M42 to collaborate in drug …
ONWARD Medical Advances Brain-Computer Interface Leadership with Fourth and Fifth Successful BCI Implants
GlobeNewswire
·
May 21, 2025
Groundbreaking procedures extend ONWARD’s leadership in the rapidly emerging brain-computer interface (BCI) field ARC-BCI Therapy is designed to restore thought-driven movement after spinal cord injury and other movement disabilities ONWARD’s BCI …
Augustine Therapeutics appoints Rie Schultz Hansen, PhD as Chief Scientific Officer and establishes Copenhagen-based subsidiary
GlobeNewswire
·
May 21, 2025
Augustine Therapeutics appoints Rie Schultz Hansen, PhD as Chief Scientific Officer and establishes Copenhagen-based subsidiary New recruit expands senior team capabilities as the business progresses its lead HDAC6 inhibitor program, AGT-100216, into the …
SYNDEO Medical Announces ISO 13485 Certification, Expanding Regulatory Portfolio and Supporting Global Growth Strategy
GlobeNewswire
·
May 21, 2025
ZAVENTEM, Belgium, May 20, 2025 (GLOBE NEWSWIRE) -- SYNDEO Medical, a Belgian-based developer of interventional procedure solutions, is pleased to announce that it has received ISO 13485 certification for its quality management system. This internationally …